RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000019.xml
Fortschr Neurol Psychiatr 2010; 78(6): 360-370
DOI: 10.1055/s-0029-1245173
DOI: 10.1055/s-0029-1245173
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York
Cannabisbezogene Störungen
Teil II: Psychiatrische und somatische Folgestörungen und KomorbiditätenCannabis Use DisordersPart II: Psychiatric and Somatic Sequelae and ComorbiditiesWeitere Informationen
Publikationsverlauf
Publikationsdatum:
22. Februar 2010 (online)

Lernziele
Kenntnisse über
die körperlichen und psychischen Folgestörungen der Cannabisabhängigkeit, die körperlichen und psychischen Begleiterkrankungen der Cannabisabhängigkeit.
Literatur
- 1 Bonnet U, Scherbaum N. Evidenzbasierte Behandlung der Cannabisabhängigkeit. Backmund M Suchttherapie Landsberg; Ecomed 2007
Kap. IX 3 . 1-28MissingFormLabel - 2
Dannon P N, Lowengrup K, Amiaz R. et al .
Comorbid cannabis use and panic disorder: short term and long term follow-up.
Hum Psychopharmacology.
2004;
19
97-101
MissingFormLabel
- 3
Johns A.
Psychiatric effects of cannabis.
British J Psychiatr.
2001;
178
116-122
MissingFormLabel
- 4
Degenhardt L, Hall W, Lynskey M.
Alcohol, cannabis and tobacco use among Australians: a comparison of their associations
with other drug use and use disorders, affective and anxiety disorders, and psychosis.
Addiction.
2001;
96
1603-1614
MissingFormLabel
- 5 Bonnet U, Harries-Hedder K, Leweke F M. et al .AWMF-Leitlinie: Cannabis-bezogene Störungen. LG Schmidt, M Gastpar, P Falkai, et al Evidenzbasierte Suchtmedizin Köln; Deutscher Ärzte-Verlag 2006: 143-170
MissingFormLabel
- 6
Budney A J, Hughes J R, Moore B A. et al .
Review of the validity and significance of cannabis withdrawal syndrome.
Am J Psychiatry.
2004;
161
1967-1977
MissingFormLabel
- 7
Budney A J, Vandrey R G, Hughes J R. et al .
Comparison of cannabis and tobacco withdrawal : severity and contribution to relapse.
J Substance Abuse treat.
2008;
35
362-368
MissingFormLabel
- 8
Cornelius J R, Chung T, Martin C. et al .
Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence
and major depression, and is associated with rapid relapse to dependence.
Addict Behav.
2008;
33
1500-1505
MissingFormLabel
- 9
Benyamina A, Lecacheux M, Blecha L. et al .
Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence.
Expert Rev Neurother.
2008;
8
479-491
MissingFormLabel
- 10
Nunez L A, Gurpegui M.
Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia.
Acta Psychiatr Scand.
2002;
105
173-178
MissingFormLabel
- 11
Leweke F M, Koethe D.
Cannabis and psychiatric disorders: it is not only addiction.
Addict Biol.
2008;
13
264-275
MissingFormLabel
- 12
Gaillard M C, Borruat F X.
Persisting visual hallucinations and illusions in previosly drug-addicted patients.
Klin Montsbl Augenheilk.
2003;
220
176-178
MissingFormLabel
- 13 Täschner K L. Cannabis. Biologie, Konsum und Wirkung. Köln; Deutscher Ärzte-Verlag 2005
MissingFormLabel
- 14
Pope H G, Gruber A J, Hudson J I. et al .
Neuropsychological performance in long-term cannabis users.
Arch Gen Psychiatry.
2001;
56
909-915
MissingFormLabel
- 15
Grant Jr I, Gonzales R, Carey C L. et al .
Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study.
Journal of the International Neuropsychological Society.
2003;
9
679-689
MissingFormLabel
- 16
Solowji N, Roffman R A, Barbor T. et al .
Cognitive functioning of long-term heavy cannabis users seeking treatment.
JAMA.
2002;
287
1123-1131
MissingFormLabel
- 17
Fried P A.
Current and former marijuana use: preliminary findings of a longitudinal study of
effects on IQ in young adults.
Canadian Medical Association Journal.
2002;
166
887-891
MissingFormLabel
- 18
Bolla K I.
Dose related neurocognitive effects of marijuana use.
Neurology.
2002;
59
1337-1343
MissingFormLabel
- 19
Pope jr H G, Gruber A J, Hudson J I. et al .
Early-onset cannabis use and cognitive deficits: what is the nature of the association?.
Drug Alcohol Depend.
2003;
69
303-310
MissingFormLabel
- 20 Petersen K U, Thomasius R. Auswirkungen von Cannabiskonsum und -missbrauch. Eine Expertise zu gesundheitlichen
und psychosozialen Folgen. Ein systematisches Review der international publizierten
Studien von 1996 – 2006. Lengerich; Pabst-Verlag 2007
MissingFormLabel
- 21
Kendler K S, Prescott C A.
Cannabis use, abuse, and dependence in a population-based sample of female twins.
Am J Psychiatry.
1998;
155
1016-1022
MissingFormLabel
- 22
Kandel D, Chen K.
Types of marihuana users by longitudinal course.
J Stud Alcohol.
2000;
61
367-378
MissingFormLabel
- 23
Henquet C, Krabbendam L, Graaf de R. et al .
Cannabis use and expression of mania in the general population.
J Affect Disord.
2006;
95
103-10
MissingFormLabel
- 24
Harder V S, Morral A R, Arkes J.
Marijuana use and depression among adults: testing for causal associations.
Addiction.
2006;
101
1463-1472
MissingFormLabel
- 25
Watzke A B, Schmidt C O, Zimmermann J. et al .
Personality disorders in a clinical sample of cannabis dependent young adults.
Fortschr Neurol Psychiatr.
2008;
76
600-605
MissingFormLabel
- 26
Tournier M, Sorbara F, Gindre C. et al .
Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical
population.
Psychiatry Res.
2003;
118
1-8
MissingFormLabel
- 27
Green A I, Burgess E S, Dawson R. et al .
Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone.
Schizophr res.
2003;
60
81-85
MissingFormLabel
- 28
Stuyt E B, Sajbel T A, Allen M H.
Differing effects of antipsychotic medications on substance abuse treatment patients
with co-occurring psychotic and substance abuse disorders.
Am J Addict.
2006;
15
166-173
MissingFormLabel
- 29
Potvin S, Stip E, Lipp O. et al .
Quetiapine in patients with comorbid schizophrenia-spectrum and substance disorders:
an open-label trial.
Curr Med Res Opin.
2006;
22
1277-1285
MissingFormLabel
- 30
Van Nimwegen L J, Haan de L, Beberen N J. et al .
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis
in patients with schizophrenia or related disorders: a double-blind randomized controlled
trial.
Can J Psychiatry.
2008;
53
400-405
MissingFormLabel
- 31
Edwards van J, Elkins K, Hinton M. et al .
Randomized controlled trial of a cannabis-focused intervention for people with first-episode
psychosis.
Acta Psychiatr Scand.
2006;
114
109-117
MissingFormLabel
- 32
Bellack A s, Bennett M E, Gearon J S. et al .
A randomized clinical trial of a behavioral treatment for drug abuse in people with
severe and persistent mental illness.
Arch Gen Psychiatry.
2006;
63
426-432
MissingFormLabel
- 33
Sigmon S C, Higgins S T.
Voucher-based contingent reinforcement of marijuana abstinence among individuals with
serious mental illness.
J Subst Abuse Treat.
2006;
30
291-295
MissingFormLabel
- 34
Fergusson D M, Horwood J.
Does cannabis use encourage other forms of illicit drug use?.
Addiction.
2000;
95
505-520
MissingFormLabel
- 35 Simon R, Sonntag D, Bühringer G. et al .Cannabisbezogene Störungen: Umfang, Behandlungsbedarf und Behandlungsangebot in Deutschland. München; IFT 2004
MissingFormLabel
- 36
Jones R T.
Cardiovascular system effects of marijuana.
J Clin Pharmacol.
2002;
42 (11 Suppl)
58S-63S
MissingFormLabel
- 37
Peyrot I, Garsaud A M, Saint-Cyr I. et al .
Cannabis arteriitis: a new case report and a review of literature.
J Eur Acad Dermatol Venereol.
2007;
21
388-391
MissingFormLabel
- 38
Wargo K A, Geveden B, McConnell V J.
Cannabinoid-induced pancreatitis: a case series.
JOP.
2007 (online);
8
579-583
MissingFormLabel
- 39
Boratyrewicz M, Urasinska E, Rozanski J. et al .
Membranous glomerulonephritis may be associated with heavy marijuana abuse.
Transplant Proc.
2007;
39
3054-3056
MissingFormLabel
- 40
Schwartz R H.
Marijuana: a decade and a half later, still a crude drug with underappreciated toxicity.
Pediatrics.
2002;
109
284-289
MissingFormLabel
- 41
Allen J H, Moore G M, Twartz J C.
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis
abuse.
Gut.
2004;
53
1566-1570
MissingFormLabel
- 42
Hezode de C, Zafrani E S, Roudot-Thoraval F. et al .
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic
hepatitis C?.
Gastroenterology.
2008;
134
432-439
MissingFormLabel
- 43
Weintrieb R M, Lucey M R.
Treatment of addictive behaviors in liver transplant patients.
Liver Transplantation.
2007;
13 (Suppl 2)
S79-S82
MissingFormLabel
- 44
Taylor D R, Fergusson D M, Milne B J. et al .
A longitudinal study of the effects of tobacco and cannabis exposure on lung function
in young adults.
Addiction.
2002;
97
1055-1061
MissingFormLabel
- 45
Fried P A, Smith A M.
A literature review of the consequences of prenatal marihuana exposure: an emerging
theme of a deficiency in aspects of executive function.
Neurotoxicol Teratol.
2001;
23
1-11
MissingFormLabel
- 46
Busse F P, Fiedler G M, Leichtle A. et al .
Bleiintoxikationen durch gestrecktes Marihuana in Leipzig.
Deutsches Ärzteblatt.
2008;
105
757-62
MissingFormLabel
- 47
Brandenburg D, Wernick R.
Intraveneous marijuana syndrome.
West J Med.
1986;
145
94-96
MissingFormLabel
- 48
Robson P.
Human studies of cannabinoids and medical cannabis.
Handb Exp Pharmacol.
2005;
168
719-756
MissingFormLabel
Prof. Dr. med. Udo Bonnet
Klinik für abhängiges Verhalten und Suchtmedizin, Klinik für Psychiatrie und Psychotherapie,
Universität Duisburg/Essen, LVR-Klinikum Essen
Virchowstr. 174
45147 Essen
eMail: udo.bonnet@lvr.de